Mesh versus non-mesh for emergency groin hernia repair.


Journal

The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747

Informations de publication

Date de publication:
27 11 2023
Historique:
pmc-release: 27 11 2024
medline: 29 11 2023
pubmed: 27 11 2023
entrez: 27 11 2023
Statut: epublish

Résumé

A groin hernia is a collective name for inguinal and femoral hernias, which can present acutely with incarceration or strangulation of the hernia sac content, requiring emergency treatment. Timely repair of emergency groin hernias is crucial due to the risk of reduced blood supply and thus damage to the bowel, but the optimal surgical approach is unclear. While mesh repair is the standard treatment for elective hernia surgery, using mesh for emergency groin hernia repair remains controversial due to the risk of surgical site infection. To assess the benefits and harms of mesh compared with non-mesh in emergency groin hernia repair in adult patients with an inguinal or femoral hernia. On 5 August 2022, we searched the following databases: CENTRAL, MEDLINE Ovid, and Embase Ovid, as well as two trial registers for ongoing and completed trials. Additionally, we performed forward and backward citation searches for the included trials and relevant review articles. We searched without any language or publication restrictions. We included randomised controlled trials (RCTs) comparing mesh with non-mesh repair in emergency groin hernia surgery in adults. We included any mesh and any non-mesh repairs. All studies fulfilling the study, participant, and intervention criteria were included irrespective of reported outcomes. We used standard Cochrane methodology. We presented dichotomous data as risk ratios (RR) with 95% confidence intervals (CI). We based missing data analysis on best- and worst-case scenarios. For outcomes with sufficiently low heterogeneity, we performed meta-analyses using the random-effects model. We analysed subgroups when feasible, including the degree of contamination. We used RoB 2 for risk of bias assessment, and summarised the certainty of evidence using GRADE. We included 15 trials randomising 1241 participants undergoing emergency groin hernia surgery with either mesh (626 participants) or non-mesh hernia repair (615 participants). The studies were conducted in China, the Middle East, and South Asia. Most patients were men, and most participants had an inguinal hernia (41 participants had femoral hernias). The mean/median age in the mesh group ranged from 35 to 70 years, and from 41 to 69 years in the non-mesh group. All studies were performed in a hospital emergency setting (tertiary care) and lasted for 11 to 139 months, with a median study duration of 31 months. The majority of the studies only included participants with clean to clean-contaminated surgical fields. For all outcomes, we considered the certainty of the evidence to be very low, mainly downgraded due to high risk of bias (due to deviations from intended intervention and missing outcome data), indirectness, and imprecision. Mesh hernia repair may have no effect on or slightly increase the risk of 30-day surgical site infections (RR 1.66, 95% CI 0.96 to 2.88; I² = 21%; 2 studies, 454 participants) when compared with non-mesh hernia repair, but the evidence is very uncertain. The evidence is also very uncertain about the effect of mesh hernia repair compared with non-mesh hernia repair on 30-day mortality (RR 1.38, 95% CI 0.58 to 3.28; 1 study, 208 participants). In summary, the results showed 70 more (from 5 fewer to 200 more) surgical site infections and 29 more (from 32 fewer to 175 more) deaths within 30 days of mesh hernia repair per 1000 participants compared with non-mesh hernia repair. The evidence is very uncertain about 90-day surgical site infections after mesh versus non-mesh hernia repair (RR 1.00, 95% CI 0.15 to 6.64; 1 study, 60 participants; very low-certainty evidence). No 30-day recurrences were recorded, and mesh hernia repair may not reduce recurrence within one year (RR 0.19, 95% CI 0.04 to 1.03; I² = 0%; 2 studies, 104 participants; very low-certainty evidence). Within 30 days of hernia repair, no meshes were removed from clean to clean-contaminated fields, but 6.7% of meshes (1 study, 208 participants) were removed from contaminated to dirty surgical fields. Among the four studies reporting 90-day mesh removal, no events occurred. We were not able to identify any studies reporting complications classified according to the Clavien-Dindo Classification or reoperation for complications within 30 days of repair. Our results show that in terms of 30-day surgical site infections, 30-day mortality, and hernia recurrence within one year, the evidence for the use of mesh hernia repair compared with non-mesh hernia repair in emergency groin hernia surgery is very uncertain. Unfortunately, firm conclusions cannot be drawn due to very low-certainty evidence and meta-analyses based on small-sized and low-quality studies. There is a need for future high-quality RCTs or high-quality registry-based studies if RCTs are unfeasible.

Sections du résumé

BACKGROUND
A groin hernia is a collective name for inguinal and femoral hernias, which can present acutely with incarceration or strangulation of the hernia sac content, requiring emergency treatment. Timely repair of emergency groin hernias is crucial due to the risk of reduced blood supply and thus damage to the bowel, but the optimal surgical approach is unclear. While mesh repair is the standard treatment for elective hernia surgery, using mesh for emergency groin hernia repair remains controversial due to the risk of surgical site infection.
OBJECTIVES
To assess the benefits and harms of mesh compared with non-mesh in emergency groin hernia repair in adult patients with an inguinal or femoral hernia.
SEARCH METHODS
On 5 August 2022, we searched the following databases: CENTRAL, MEDLINE Ovid, and Embase Ovid, as well as two trial registers for ongoing and completed trials. Additionally, we performed forward and backward citation searches for the included trials and relevant review articles. We searched without any language or publication restrictions.
SELECTION CRITERIA
We included randomised controlled trials (RCTs) comparing mesh with non-mesh repair in emergency groin hernia surgery in adults. We included any mesh and any non-mesh repairs. All studies fulfilling the study, participant, and intervention criteria were included irrespective of reported outcomes.
DATA COLLECTION AND ANALYSIS
We used standard Cochrane methodology. We presented dichotomous data as risk ratios (RR) with 95% confidence intervals (CI). We based missing data analysis on best- and worst-case scenarios. For outcomes with sufficiently low heterogeneity, we performed meta-analyses using the random-effects model. We analysed subgroups when feasible, including the degree of contamination. We used RoB 2 for risk of bias assessment, and summarised the certainty of evidence using GRADE.
MAIN RESULTS
We included 15 trials randomising 1241 participants undergoing emergency groin hernia surgery with either mesh (626 participants) or non-mesh hernia repair (615 participants). The studies were conducted in China, the Middle East, and South Asia. Most patients were men, and most participants had an inguinal hernia (41 participants had femoral hernias). The mean/median age in the mesh group ranged from 35 to 70 years, and from 41 to 69 years in the non-mesh group. All studies were performed in a hospital emergency setting (tertiary care) and lasted for 11 to 139 months, with a median study duration of 31 months. The majority of the studies only included participants with clean to clean-contaminated surgical fields. For all outcomes, we considered the certainty of the evidence to be very low, mainly downgraded due to high risk of bias (due to deviations from intended intervention and missing outcome data), indirectness, and imprecision. Mesh hernia repair may have no effect on or slightly increase the risk of 30-day surgical site infections (RR 1.66, 95% CI 0.96 to 2.88; I² = 21%; 2 studies, 454 participants) when compared with non-mesh hernia repair, but the evidence is very uncertain. The evidence is also very uncertain about the effect of mesh hernia repair compared with non-mesh hernia repair on 30-day mortality (RR 1.38, 95% CI 0.58 to 3.28; 1 study, 208 participants). In summary, the results showed 70 more (from 5 fewer to 200 more) surgical site infections and 29 more (from 32 fewer to 175 more) deaths within 30 days of mesh hernia repair per 1000 participants compared with non-mesh hernia repair. The evidence is very uncertain about 90-day surgical site infections after mesh versus non-mesh hernia repair (RR 1.00, 95% CI 0.15 to 6.64; 1 study, 60 participants; very low-certainty evidence). No 30-day recurrences were recorded, and mesh hernia repair may not reduce recurrence within one year (RR 0.19, 95% CI 0.04 to 1.03; I² = 0%; 2 studies, 104 participants; very low-certainty evidence). Within 30 days of hernia repair, no meshes were removed from clean to clean-contaminated fields, but 6.7% of meshes (1 study, 208 participants) were removed from contaminated to dirty surgical fields. Among the four studies reporting 90-day mesh removal, no events occurred. We were not able to identify any studies reporting complications classified according to the Clavien-Dindo Classification or reoperation for complications within 30 days of repair.
AUTHORS' CONCLUSIONS
Our results show that in terms of 30-day surgical site infections, 30-day mortality, and hernia recurrence within one year, the evidence for the use of mesh hernia repair compared with non-mesh hernia repair in emergency groin hernia surgery is very uncertain. Unfortunately, firm conclusions cannot be drawn due to very low-certainty evidence and meta-analyses based on small-sized and low-quality studies. There is a need for future high-quality RCTs or high-quality registry-based studies if RCTs are unfeasible.

Identifiants

pubmed: 38009575
doi: 10.1002/14651858.CD015160.pub2
pmc: PMC10680123
doi:

Banques de données

ClinicalTrials.gov
['NCT02469142']

Types de publication

Systematic Review Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

CD015160

Informations de copyright

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Références

JAMA Surg. 2022 Apr 01;157(4):293-301
pubmed: 35044431
Hernia. 2005 May;9(2):156-9
pubmed: 15690104
Hernia. 2014 Jun;18(3):399-406
pubmed: 23475313
Surg Today. 2007;37(3):212-4
pubmed: 17342359
Eur J Vasc Endovasc Surg. 2007 Sep;34(3):253-6
pubmed: 17689818
Int J Surg. 2008 Aug;6(4):302-5
pubmed: 18573702
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
World J Surg. 2014 Nov;38(11):2784-90
pubmed: 25135172
Surg Endosc. 2005 May;19(5):605-15
pubmed: 15789255
Langenbecks Arch Surg. 2014 Jun;399(5):571-7
pubmed: 24789811
Pak J Med Sci. 2017 May-Jun;33(3):699-702
pubmed: 28811798
Am Surg. 2018 Feb 1;84(2):215-219
pubmed: 29580348
J Am Coll Surg. 2011 Sep;213(3):363-9
pubmed: 21680204
Cochrane Database Syst Rev. 2017 Feb 07;2:CD010814
pubmed: 28170080
J Gastrointest Surg. 2020 Jan;24(1):221-230
pubmed: 31637626
Hernia. 2012 Aug;16(4):397-403
pubmed: 22695978
Cochrane Database Syst Rev. 2002;(4):CD002197
pubmed: 12519568
Langenbecks Arch Surg. 2010 Jun;395(5):563-8
pubmed: 18758807
Surg Innov. 2020 Aug;27(4):352-357
pubmed: 31994450
Hernia. 2018 Dec;22(6):1045-1050
pubmed: 30145621
Int J Clin Pract. 2004 Feb;58(2):207-9
pubmed: 15055870
Hernia. 2022 Aug;26(4):1131-1141
pubmed: 35348925
Front Surg. 2015 Sep 15;2:48
pubmed: 26442279
Hernia. 2022 Feb;26(1):217-223
pubmed: 34138368
Hernia. 2015 Dec;19(6):909-14
pubmed: 25731947
Int J Epidemiol. 1996 Aug;25(4):835-9
pubmed: 8921464
Surgery. 2015 Feb;157(2):189-93
pubmed: 25304841
J Clin Epidemiol. 2020 Mar;119:126-135
pubmed: 31711912
Br J Surg. 1991 Oct;78(10):1171-3
pubmed: 1958976
Surg Endosc. 2022 Nov;36(11):7961-7973
pubmed: 35641700
Cochrane Database Syst Rev. 2023 Nov 27;11:CD015160
pubmed: 38009575
BMJ. 2005 Nov 5;331(7524):1064-5
pubmed: 16230312
Ann Surg. 2009 Apr;249(4):672-6
pubmed: 19300219
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Cochrane Database Syst Rev. 2003;(1):CD001785
pubmed: 12535413
Hernia. 2019 Jun;23(3):523-539
pubmed: 30689077
Hernia. 2010 Aug;14(4):351-5
pubmed: 20396920
Cochrane Database Syst Rev. 2018 Sep 13;9:CD011517
pubmed: 30209805
Surg Today. 2012 Apr;42(4):359-62
pubmed: 22068673
Am Surg. 2002 Jun;68(6):524-8; discussion 528-9
pubmed: 12079133
Infect Control Hosp Epidemiol. 1999 Nov;20(11):725-30
pubmed: 10580621
Hernia. 2018 Feb;22(1):1-165
pubmed: 29330835
Surg Infect (Larchmt). 2020 May;21(4):344-349
pubmed: 31816266
Ann Med Surg (Lond). 2020 Dec 02;60:664-668
pubmed: 33312559
World J Surg. 2020 Jul;44(7):2176-2184
pubmed: 32086555
Ann Surg. 2007 Apr;245(4):656-60
pubmed: 17414617
Front Surg. 2021 Mar 30;8:655755
pubmed: 33859994
Int J Surg. 2008 Jun;6(3):189-92
pubmed: 18406674
Wound Repair Regen. 2016 Mar;24(2):427-33
pubmed: 26609642
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Ann Hou Sæter (AH)

Center for Perioperative Optimization, Department of Surgery, Herlev Hospital, Herlev, Denmark.

Siv Fonnes (S)

Center for Perioperative Optimization, Department of Surgery, Herlev Hospital, Herlev, Denmark.

Shuqing Li (S)

Evidence-based Medicine Research Center, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

Jacob Rosenberg (J)

Center for Perioperative Optimization, Department of Surgery, Herlev Hospital, Herlev, Denmark.

Kristoffer Andresen (K)

Center for Perioperative Optimization, Department of Surgery, Herlev Hospital, Herlev, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH